Inovio Pharmaceuticals, Inc. (INO) financial statements (2021 and earlier)

Company profile

Business Address 6769 MESA RIDGE RD.
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:412908112710516394
Cash and cash equivalents251222424195841
Short-term investments16167581048610553
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)(0)    
Receivables192461773
Prepaid expense5      
Other undisclosed current assets36334323
Total current assets:471948813812517299
Noncurrent Assets
Operating lease, right-of-use asset1314✕✕✕✕✕
Property, plant and equipment11131618975
Long-term investments and receivables0 99161513
Long-term investments0 99161513
Intangible assets, net (including goodwill)14141517181415
Goodwill11111111111010
Intangible assets, net (excluding goodwill)3456845
Other noncurrent assets26333210
Other undisclosed noncurrent assets460245 
Total noncurrent assets:69504349494233
TOTAL ASSETS:540144131187174214132
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2118232320136
Accrued liabilities  69632
Employee-related liabilities13998743
Other undisclosed accounts payable and accrued liabilities8987761
Deferred revenue00✕✕✕✕✕
Debt 2     
Deferred rent credit  1✕✕✕✕
Due to related parties1111100
Deferred revenue and credits✕✕✕215143
Contract with customer, liability✕✕0✕✕✕✕
Other undisclosed current liabilities2011109844
Total current liabilities:42323535443114
Noncurrent Liabilities
Long-term debt and lease obligation1820     
Operating lease, liability1820✕✕✕✕✕
Liabilities, other than long-term debt0999665
Deferred revenue and credits✕✕✕9665
Deferred revenue00✕✕✕✕✕
Contract with customer, liability✕✕0✕✕✕✕
Deferred rent credit  9✕✕✕✕
Deferred tax liabilities, net✕✕  001
Deferred income tax liabilities00✕✕✕✕✕
Other liabilities000    
Derivative instruments and hedges, liabilities 9     
Other undisclosed noncurrent liabilities197700011
Total noncurrent liabilities:3710799766
Total liabilities:791394445503820
Stockholders' equity
Stockholders' equity attributable to parent, including:461387142123176111
Common stock0000000
Additional paid in capital1,367743708666557534443
Accumulated other comprehensive income (loss)(0)0(1)(0)13(0)
Accumulated deficit(906)(740)(620)(523)(435)(361)(332)
Warrants and rights outstanding      2
Other undisclosed stockholders' equity attributable to parent      (2)
Stockholders' equity attributable to noncontrolling interest 200000
Total stockholders' equity:461587142123176112
TOTAL LIABILITIES AND EQUITY:540144131187174214132

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net✕✕✕42354110
Net investment income33     
Gross profit:743042354110
Operating expenses(131)(115)(125)(126)(112)(75)(50)
Operating loss:(124)(111)(94)(84)(76)(34)(39)
Nonoperating income (expense)30    (0)
Investment income, nonoperating4     (0)
Other nonoperating income (expense)(1)0     
Interest and debt expense(9)(8)     
Loss from continuing operations before equity method investments, income taxes:(129)(119)(94)(84)(76)(34)(40)
Other undisclosed income (loss) from continuing operations before income taxes(34)(2)(1)(5)23 
Loss from continuing operations before income taxes:(163)(121)(95)(88)(74)(31)(40)
Income tax expense (benefit) 0(2)  2(0)
Loss before gain (loss) on sale of properties:(163)(121)(97)(88)(74)(29)(40)
Other undisclosed net income (loss)(5)     3
Net loss:(167)(121)(97)(88)(74)(29)(36)
Net income (loss) attributable to noncontrolling interest11   (0)0
Net loss attributable to parent:(166)(119)(97)(88)(74)(29)(36)
Other undisclosed net loss available to common stockholders, basic   (1) (1)(2)
Net loss available to common stockholders, diluted:(166)(119)(97)(89)(74)(30)(38)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(167)(121)(97)(88)(74)(29)(36)
Other comprehensive income 0     
Other undisclosed comprehensive income (loss)(1)1(0)(1)(1)3(0)
Comprehensive loss:(168)(120)(97)(90)(75)(26)(36)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest11   (0)0
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     0(0)
Comprehensive loss, net of tax, attributable to parent:(167)(118)(97)(90)(75)(26)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: